Half-year report · Q2
1783.TEDINET S100VQH7
Period2024-10-01 → 2025-03-31
Filed2025-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.8bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥8.8bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.0bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥16m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥54m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | −¥205m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥664m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥40m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥202m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥118m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥216m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥291m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥73m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥216m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥73m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥9.5bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥14.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥8.4bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.1bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.6bn | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.4bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.6bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.4bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.0bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.0bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥4.0bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥2.7bn | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥750m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥706m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥109m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.5bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.8bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.4bn | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-1.27 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.71 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.43 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 67.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 35
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-03-31 | −¥46m |
| Reconciling Itemsreconciling | revenue external | 2024-10-01 → 2025-03-31 | ¥207,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-03-31 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥329m |
| jpcrp040300-q2r_E00263-000Clean Enagy Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥82m |
| jpcrp040300-q2r_E00263-000Clean Enagy Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥82m |
| jpcrp040300-q2r_E00263-000Clean Enagy Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥27m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥119m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥72m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥47m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥6m |
| jpcrp040300-q2r_E00263-000Real Estatereportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥6.7bn |
| jpcrp040300-q2r_E00263-000Real Estatereportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥6.7bn |
| jpcrp040300-q2r_E00263-000Real Estatereportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥324m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥6.9bn |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥6.8bn |
| —segment total | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥47m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥345m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥44m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥44m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥304m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥277m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥233m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥44m |
| jpcrp040300-q2r_E00263-000Healthcare Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥52m |
| jpcrp040300-q2r_E00263-000Real Estatereportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥4.8bn |
| jpcrp040300-q2r_E00263-000Real Estatereportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥4.8bn |
| jpcrp040300-q2r_E00263-000Real Estatereportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥313m |
| jpcrp040300-q2r_E00263-000Real Estate Consulting Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥19m |
| jpcrp040300-q2r_E00263-000Real Estate Consulting Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥19m |
| jpcrp040300-q2r_E00263-000Real Estate Consulting Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥8m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥5.1bn |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥5.0bn |
| —segment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥44m |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | ¥357m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 509
| Item | Context | Value | Unit |
|---|---|---|---|
| Commission fee sga | Prior1YTDDuration | 122751000 | JPY |
| Commission fee sga | CurrentYTDDuration | 59757000 | JPY |
| Amortization of goodwill sga | Prior1YTDDuration | 164175000 | JPY |
| Amortization of goodwill sga | CurrentYTDDuration | 163425000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | -883000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -11917000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00263-000RealEstateReportableSegmentsMember | 4766784000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00263-000HealthcareBusinessReportableSegmentMember | 232624000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00263-000RealEstateConsultingBusinessReportableSegmentMember | 18731000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 5018139000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 5018139000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00263-000RealEstateReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00263-000HealthcareBusinessReportableSegmentMember | 44375000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00263-000RealEstateConsultingBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 44375000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -44375000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00263-000RealEstateReportableSegmentsMember | 4766784000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00263-000HealthcareBusinessReportableSegmentMember | 276999000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00263-000RealEstateConsultingBusinessReportableSegmentMember | 18731000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 5062514000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -44375000 | JPY |
| Net sales | Prior1YTDDuration | 5018139000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00263-000RealEstateReportableSegmentsMember | 313366000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00263-000HealthcareBusinessReportableSegmentMember | 51909000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00263-000RealEstateConsultingBusinessReportableSegmentMember | -8022000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 357253000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -303584000 | JPY |
| Operating income | Prior1YTDDuration | 53669000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00263-000RealEstateReportableSegmentsMember | 6661520000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00263-000HealthcareBusinessReportableSegmentMember | 72202000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00263-000CleanEnagyBusinessReportableSegmentMember | 82400000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 6816122000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | 207000 | JPY |
| Revenues from external customers | CurrentYTDDuration | 6816330000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00263-000RealEstateReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00263-000HealthcareBusinessReportableSegmentMember | 46513000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00263-000CleanEnagyBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 46513000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -46513000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00263-000RealEstateReportableSegmentsMember | 6661520000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00263-000HealthcareBusinessReportableSegmentMember | 118716000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00263-000CleanEnagyBusinessReportableSegmentMember | 82400000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 6862636000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -46306000 | JPY |
| Net sales | CurrentYTDDuration | 6816330000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E00263-000RealEstateReportableSegmentsMember | 323933000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E00263-000HealthcareBusinessReportableSegmentMember | -6222000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |